E M Shatzen
Overview
Explore the profile of E M Shatzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shalhoub V, Shatzen E, Ward S, Young J, Boedigheimer M, Twehues L, et al.
J Cell Biochem
. 2010 Jul;
111(4):911-21.
PMID: 20665672
Vitamin D sterol administration, a traditional treatment for secondary hyperparathyroidism, may increase serum calcium and phosphorus, and has been associated with increased vascular calcification (VC). In vitro studies suggest that...
2.
Hartung T, Pitrak D, Foote M, Shatzen E, Verral S, Wendel A
J Infect Dis
. 1998 Sep;
178(3):686-92.
PMID: 9728536
Filgrastim induces lymphocytosis, including all T cell subsets, and increased ex vivo interleukin (IL)-2 release as well as lymphocyte proliferation. Since Filgrastim is increasingly used in patients with human immunodeficiency...
3.
Stevens P, Scott R, Shatzen E
Agents Actions Suppl
. 1993 Jan;
39:173-7.
PMID: 8384402
Cartilage degradation is mediated by activated matrix metalloproteinases (MMP). Since the plasmin/plasminogen cascade may activate latent MMP during cartilage catabolism, we determined if protease nexin-1 (PN-1), an inhibitor of plasminogen,...
4.
Stevens P, Shatzen E
Agents Actions
. 1991 Sep;
34(1-2):217-9.
PMID: 1793034
Interleukin-1 beta (IL-1) and basic fibroblast growth factor (bFGF) synergistically induce proteases in vitro. To investigate this synergy in vivo, we injected IL-1 and bFGF alone and in combination into...